April 2003 Bulletin

In Related News–Cryolife agreement

The FDA extended its agreement with Cryolife, Inc. until June 13, 2003 to prohibit distribution of most human allografts. Cryolife is expected to resume processing tissue for orthopaedic applications following inspections by the FDA.


Home Previous Page